A new metabolite contributing to N-acetyl signal in 1H MRS of the brain in Salla disease

Neurology

Volumn 52, Issue 8, 1999, Pages 1668-1672

  Varho, Tarja ^a   Komu, M ^b   Sonninen, P ^b   Holopainen, I ^b   Nyman, S ^b   Manner, T ^b   Sillanpaa M ^b   Aula, P ^b   Lundbom, N ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID; N ACETYLNEURAMINIC ACID; SIALIC ACID;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BASAL GANGLION; BRAIN METABOLISM; CANAVAN DISEASE; CHILD; CLINICAL ARTICLE; DEGENERATIVE DISEASE; HUMAN; LYSOSOME; LYSOSOME STORAGE DISEASE; MYELINATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIALIC ACID STORAGE DISEASE; WHITE MATTER;

EID: 0033549025     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.8.1668     Document Type: Article

References (33)

1. Kristjánsdóttir R, Uvebrant P, Hagberg B, et al. Disorders of the cerebral white matter in children. The spectrum of lesions. Neuropediatrics 1996;27:295-298.
2. Autti T, Raininko R, Vanhanen SL, Santavuori P. Magnetic resonance techniques in neuronal ceroid lipofuscinoses and some other lysosomal diseases affecting the brain. Curr Opin Neurol 1997;10:519-524.
3. Haataja L, Parkkola R, Sonninen P. et al. Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder. Neuropediatrics 1994;25:238-244.
4. Robinson RO, Fensom AH, Lake BD. Salla disease - rare or underdiagnosed? Dev Med Child Neurol 1997;39:153-157.
5. Aula P, Autio S, Raivio KO, et al. "Salla disease." A new lysosomal storage disorder. Arch Neurol 1979;36:88-94.
6. Renlund M, Aula P, Raivio KO, et al. Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism. Neurology 1983;44:57-66.
7. Renlund M, Tietze F, Gahl WA. Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease. Science 1986;232:759-762.
8. Mancini GMS, de Jonge HR, Galjaard H, Verheijen FW. Characterization of a proton-driven carrier for sialic acid in the lysosomal membrane. Evidence for a group-specific transport system for acidic monosaccharides. J Biol Chem 1989;264: 15247-15254.
9. Gahl WA, Schneider JA, Aula PP. Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill, 1995;3782-3797.
10. Echenne B, Vidal M, Maire I, Michalski JC, Baldet P, Astruc J. Salla disease in one non-Finnish patient. Eur J Pediatr 1986;145:320-322.
11. Fois A, Balestri P, Fnarnetani MA, et al. Free sialic acid storage disease. A new Italian case. Eur J Pediatr 1987;146: 195-198.
12. Sewell AC, Poets CF, Degen I, Stöss H, Pontz BF. The spectrum of free neuraminic acid storage disease in childhood: clinical, morphological and biochemical observations in three non-Finnish patients. Am J Med Genet 1996;63:203-208.
13. Autio-Harmainen H, Oldfors A, Sourander P, Renlund M, Dammert K, Similä S. Neuropathology of Salla disease. Acta Neuropathol 1988;75:481-490.
14. Suhonen-Polvi H, Varho T, Metsähonkala L, et al. Increased brain glucose utilization in Salla disease (free sialic acid storage disorder). J Nucl Med 1999;40:12-18.
15. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437.
16. Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics 1996;27: 64-69.
17. Michaelis T, Merboldt KD, Bruhn H, Hänicke W, Frahm J. Absolute concentrations of metabolites in adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-227.
18. Barker PB, Breiter SN, Soher BJ, et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994;32:157-163.
19. Danielsen ER, Henriksen O. Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites. NMR Biomed 1994;7(7):311-318.
20. Haataja L, Schleutker J, Laine A-P, et al. The genetic locus for free sialic acid storage disease maps to the long arm of chromosome 6. Am J Hum Genet 1994;54:1042-1049.
21. Holshauser BA, Komu M, Moeller HE, et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magn Reson Med 1995;33:589-594.
22. Lundbom N, Manner T, Komu M, Peltola O, Leino K, Kirvelä O. Do fasting and barbiturate anesthesia affect the metabolites in brain proton spectroscopy? Proc Int Soc Magn Reson Med 1996;2:991. Abstract.
23. Grodd W, Krägeloh-Mann I, Petersen D, Trefz FK, Harzer K. In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 1990;336:437-438.
24. 1H MR spectroscopy in children with Canavan's disease. J Magn Reson Imaging 1996;6:889-893.
25. Grodd W, Krageloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991;181:173-181.
26. Brockmann K, Pouwels PJW, Christen H-J, Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis. Neuropediatrics 1996;27:242-248.
27. Rajanayagam V, Grad J, Krivit W, et al. Proton MR spectroscopy of childhood adrenoleukodystrophy. AJNR Am J Neuroradiol 1996;17:1013-1024.
28. Pouwels PJW, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998;39:53-60.
29. Moffett JR, Namboodiri MA, Cangro CB, Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:131-134.
30. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989.
31. 1H NMR spectroscopy. Glutamate and glutamine; myoinositol and related metabolites. NMR Biomed 1991;4:59-63.
32. Stöckler S, Hanefeld F, Frahm J. Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 1996;348:789-790.
33. Van der Knaap MS, van der Grond J, van Rijen PC, Faber JAJ, Valk J, Willemse K. Age dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990;176:509-515.